Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.

Stouthard, J M; Goey, H; de Vries, E G; de Mulder, P H; Groenewegen, A; Pronk, L; Stoter, G; Sauerwein, H P; Bakker, P J; Veenhof, C H

Stouthard, J M; Goey, H; de Vries, E G; de Mulder, P H; Groenewegen, A; Pronk, L; Stoter, G; Sauerwein, H P; Bakker, P J; Veenhof, C H.

Affiliation

Stouthard JM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, The Netherlands.

Br J Cancer ; 73(6): 789-93, 1996 Mar.

Article in En | MEDLINE | ID: mdl-8611381

Subject(s)

Carcinoma, Renal Cell/drug therapy; Interleukin-6/therapeutic use; Kidney Neoplasms/drug therapy; Acute-Phase Reaction/chemically induced; Anemia/chemically induced; Carcinoma, Renal Cell/blood; Carcinoma, Renal Cell/immunology; Female; Hemoglobins/drug effects; Hemoglobins/metabolism; Humans; Interleukin-6/adverse effects; Interleukin-6/immunology; Kidney Neoplasms/blood; Kidney Neoplasms/immunology; Male; Middle Aged; Recombinant Proteins/adverse effects; Recombinant Proteins/immunology; Recombinant Proteins/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Interleukin-6 / Kidney Neoplasms Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 1996 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google